Sign in
Industry insight
Get a quote
Advertisement

AntiVEGF therapy

Summary

AntiVEGF therapy

Anti-VEGF, 'vascular endothelial growth factor', medication is a treatment that can help stop the progression of wet AMD. This medication Lucentis (Ranibizumab) has to be injected into the eye using a very fine needle under local anaesthetic. This typically results in prevention of further loss of vision, and can also lead to improved vision. The patient will need to be monitored for further leakage of fluid in the eye.

Eylea (Aflibercept) is also an AntiVEGF therapy and works by targeting abnormal retinal blood vessels, reducing or stopping the bleeding and leakage . This typically results in prevention of further loss of vision, and can also lead to improved vision.

Guide to going private

Guide to going private

20 page PDF guide to "going private" for insured and self-paying patients.

  • Advice on choosing a doctor and hospital
  • Checklist for comparing providers
  • Understanding prices

Download >

Costs and funding

Costs and funding
Lowest Average Highest
£558 £1,480 £6,900
Costs by region Get a quote

Features

Blog

The most commonly asked questions, answered

More from the blog  
Article

No need to wait: Video

Get expert orthopaedic care quickly at the Midland Orthopaedic Practice.

More articles  

Latest news

Work Begins at New Rutherford Diagnostics Headquarters in Liverpool

Pioneering treatment at The Tinnitus Clinic sees 90% improvement

The London Clinic launches osseointegration

More news  

Find a ...

Advertisement
Advertisement